The International Helmholtz Research School for Diabetes is at the core of cutting-edge scientific research at the Helmholtz Diabetes Center in Munich and its partner institution, the Alberta Diabetes Institute in Canada. It offers research projects that enable the development of innovative strategies for the identification of molecular mechanisms, generation of prediction tools, and advancement of therapeutic strategies for type 1 and type 2 diabetes.